Laboratory diagnostics of pheochromocytoma
https://doi.org/10.14341/probl201056439-43
Abstract
References
1. Pacak K. Preoperative management of the pheochromocytoma patient. J Clin Endocrinol Metab 2007; 92: 4069-4079.
2. Václavík J., Stejskal D., Lacnák B. et al. Free plasma metanephrines as a screening test for pheochromocytoma in low-risk patients. J Hypertens 2007; 25: 1427-1431.
3. Lo C.Y., Lam K.Y., Wat M.S., Lam K.S. Adrenal pheochromocytoma remains a frequently overlooked diagnosis. Am J Surg 2000; 179: 212-215.
4. McNeil A.R., Blok B.H., Koelmeyer T.D. et al. Phaeochromocytomas discovered during coronial autopsies in Sydney, Melbourne and Auckland. Aust NZ J Med 2000; 30: 648-652.
5. Klingler H.C., Klingler P.J., Martin Jr. J.K. et al. Pheochromocytoma. Urology 2001; 57: 1025-1032.
6. Elder E.E., Elder G., Larsson C. Pheochromocytoma and functional paraganglioma syndrome: no longer the 10% tumor. J Surg Oncol 2005; 89: 193-201.
7. Zoran E., Neumann Hartmut P.H. Familial pheochromocytoma. Hormones (Athens, Greece) 2009; 8: 1: 29-38.
8. Brown W.J., Barajas L., Waisman J., De Quattro V. Ultrastructural and biochemical correlates of adrenal and extra-adrenal pheochromocytoma. Cancer 1972; 29: 744-759.
9. Aronoff S.L., Passamani E., Borowsky B.A. et al. Norepinephrine and epinephrine secretion from a clinically epinephrine-secreting pheochromocytoma. Am J Med 1980; 69: 321-324.
10. Eisenhofer G., Rivers G., Rosas A.L. et al. Adverse drug reactions in patients with phaeochromocytoma: incidence, pre-vention and management. Drug Safety 2007; 30: 1031-1062.
11. Young W.F. Jr. Management approaches to adrenal incidentalomas: a view from Rochester, Minnesota. Endocrin Metab Clin North Am 2000; 29: 159-185.
12. Lenders J.W., Pacak K., Walther M.M. et al. Biochemical diagnosis of pheochromocytoma: which test is best? JAMA 2002; 287: 1427-1434.
13. Sawka A.M., Jaeschke R., Singh R.J., Young W.F. A comparison of biochemical tests for pheochromocytoma: measurement of fractionated plasma metanephrines compared with the combination of 24-hour urinary metanephrines and catecholamines. J Clin Endocrinol Metab 2003; 88: 553-558.
14. Taylor R.L., Singh R.J. Validation of liquid chromatography-tandem mass spectrometry method for analysis of urinary conjugated metanephrine and normetanephrine for screening of pheochromocytoma. Clin Chem 2002; 48:533-539.
15. Manger W.M. An overview of pheochromocytoma: History, current concepts, vagaries, and diagnostic challenges. Ann N.Y. Acad Sci 2006; 1073: 1-20.
16. Pacak K., Eisenhofer G., Ahlman H. et al. Pheochromocytoma: recommendations for clinical practice from the First International Symposium. October 2005. Nat Clin Pract Endocrinol Metab 2007; 3: 92-102.
17. Elliott W.J., Murphy M.B. Reduced specificity of the clonidine suppression test in patients with normal plasma catecholamine levels. Am J Med 1988; 84: 419-443.
18. Eisenhofer G., Goldstein D.S., Walther M.M. et al. Biochemical diagnosis of pheochromocytoma: how to distinguish true- from false-positive test results. J.Clin Endocrinol Metab 2003; 88: 2656-6626.
19. Kinney M.A., Narr B.J., Warner M.A. Perioperative management of pheochromocytoma. J Cardiothorac Vasc Anesth 2002; 16: 359-369.
20. Algeciras-Schimnich A., Preissner C.M., Young W.F. et al. Plasma chromogranin A or urine fractionated metanephrines follow-up testing improves the diagnostic accuracy of plasma fractionated metanephrines for pheochromocytoma. J Clin Endocrinol Metab 2008; 93:1: 91-95.
21. Giovanella L. Serum chromogranin-A assay in differential diagnosis of incidentally discovered adrenal masses. Anticancer Res 2005; 25: 1547-1550.
22. Eisenhofer G., Lenders J.W., Pacak K. Biochemical diagnosis of pheochromocytoma. Front Horm Res 2004; 31: 76-106.
23. Taupenot L., Harper K.L., O'Connor D.T. The chromogranin-secretogranin family. N Engl J Med 2003; 348: 1134-1149.
Review
For citations:
Troshina E.A., Bel'tsevich D.G., Iukina M.I. Laboratory diagnostics of pheochromocytoma. Problems of Endocrinology. 2010;56(4):39-43. https://doi.org/10.14341/probl201056439-43

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).